Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-020-00910-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2019English

Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects

Clinical Drug Investigation
MedicinePharmacology
2015English

Pharmacokinetics and Safety of Enasidenib Following Single Oral Doses in Japanese and Caucasian Subjects

Pharmacology Research and Perspectives
ToxicologyNeurologyPharmaceuticsPharmacology
2018English

Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese and Non-Asian Male Subjects

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-Iv Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism

Pharmacology & Pharmacy
2013English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2013English

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2020English

The Comparative Pharmacokinetics and Safety of the Oral Neuraminidase Inhibitor Oseltamivir When Given in Multiple Doses to Healthy Japanese and Caucasian Subjects.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy